MiR-630 suppresses breast cancer progression by targeting metadherin. - Wikidata - awgldk - TriplyDB

MiR-630 suppresses breast cancer progression by targeting metadherin.

MiR-630 suppresses breast cancer progression by targeting metadherin.

http://www.wikidata.org/entity/Q36738807

about

MTDH promotes glioma invasion through regulating miR-130b-ceRNAs.MiR-654-5p attenuates breast cancer progression by targeting EPSTI1.MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1.Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients.CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630.MiR-200c suppresses the migration of retinoblastoma cells by reversing epithelial mesenchymal transition SLC3A2, antigen of mAb 3G9, promotes migration and invasion by upregulating of mucins in gastric cancer.Stroma-derived extracellular vesicles deliver tumor-suppressive miRNAs to pancreatic cancer cells.A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2.

P2860

Q33566650-E50CCDD3-12E0-45F5-8253-336B91AF7F62 Q36878791-23CADE5E-07B4-406E-AB30-19D26F8FABA3 Q37225640-7C98831A-7C9B-45AD-B25B-CEC8BE596BA4 Q37744880-A1210CBB-80DD-4FBF-9787-9EADBE62868B Q38433669-37808CFF-D6E2-4BC0-89F0-FEDE756E3D04 Q41008499-A758C171-8F33-4936-A516-D24D06D928D6 Q41374117-AA22B58F-CC9B-4A13-9FF9-89B3920AC691 Q47101416-0B448B7D-525B-4215-815B-BF9D61DCFB26 Q49787839-43A58093-9342-4C28-909D-834AA65A46CA Q54939484-6F7931B1-1920-4907-9539-0E8C578434D4 Q55410765-951B4962-15CC-4F2A-8A66-6CAB3C6463E8

P2860

MiR-630 suppresses breast cancer progression by targeting metadherin.

http://www.wikidata.org/entity/Q36738807

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

MiR-630 suppresses breast cancer progression by targeting metadherin.

@ast

MiR-630 suppresses breast cancer progression by targeting metadherin.

@en

type

label

MiR-630 suppresses breast cancer progression by targeting metadherin.

@ast

MiR-630 suppresses breast cancer progression by targeting metadherin.

@en

prefLabel

MiR-630 suppresses breast cancer progression by targeting metadherin.

@ast

MiR-630 suppresses breast cancer progression by targeting metadherin.

@en

P1433

Q36738807-14DE999C-D32E-43F5-9225-59DB587196B4

P1476

Q36738807-4017496B-CB28-4B4C-AAE1-B256CC039C1C

P2093

Q36738807-069DFF3A-86D1-481A-BAA1-EE7E3C9E8013

Q36738807-0B769376-FAC2-4DA3-BE47-5E3CDA9675BE

Q36738807-0ECFDC00-D20D-49B3-9F94-408F38B0D386

Q36738807-1C743E75-C9E0-4AAC-8A8F-2B3AB67B93A3

Q36738807-3D0F5068-7B6A-460C-A40A-544BA628EE12

Q36738807-3DC65B02-3B9E-4CD2-B867-0DFD8903283C

Q36738807-5FF21ACF-6F07-42D2-860C-A1DF085BEF82

Q36738807-6B090889-FC33-4EB6-9F7D-FF53FAD2B125

Q36738807-74A59EF8-1353-4B21-93E4-4CF85D5C0A98

Q36738807-C1E30C2D-0E1F-4FCC-8CA1-2FD2FD13DF06

P2860

Q36738807-105FCCC7-E17A-44EA-B715-371B733BE428

Q36738807-11187878-4EA8-44FB-AE08-07C2D96B552C

Q36738807-1645EDDC-B82E-41C8-A240-09F830E846E2

Q36738807-193A6427-EF7A-4293-9DEA-41BA654FEF92

Q36738807-1EA75741-6029-414A-810C-95E73233E662

Q36738807-2199C12D-FA9D-43E1-A9C3-82FA0F05B9F6

Q36738807-2255D475-D99C-44FA-B9CE-4A6CA038BBE2

Q36738807-2367FC6C-D15E-445C-8B9B-454DA13C0878

Q36738807-251BB3B5-700E-45CF-9840-0829C9BFF813

Q36738807-2D1B3822-1957-4751-AF5A-0DAA7E58ED2F

P304

Q36738807-AA6945E3-2E0A-4515-8463-7C2D7871BB76

P31

Q36738807-65172A75-AC86-4EDA-98C0-7428C222246E

P356

Q36738807-005FE262-9D1C-45CF-BC44-33EA3AFC4543

P407

Q36738807-67179047-FD97-46FD-B413-662B591BDC39

P433

Q36738807-F0D18E24-9C2C-4B71-8805-C508014897DB

P478

Q36738807-02DA830B-E15E-4EC6-BA5B-2FAFA83F81B4

P577

Q36738807-4B8EAC28-2049-4BA6-8966-3AB2B1577E84

P5875

Q36738807-605919D3-B402-4CDF-B281-8DDB00F90439

P698

Q36738807-59F77916-A803-4FD9-B817-F6F88FCB5921

P932

Q36738807-44D9D15C-C58C-48E6-BA42-440FCF611172

P356

ONCOTARGET.6339

P1433

P1476

MiR-630 suppresses breast cancer progression by targeting metadherin.

@en

P2093

An-Lu Yu

http://www.w3.org/2001/XMLSchema#string

Chen-Long Wang

http://www.w3.org/2001/XMLSchema#string

Ci-Xiang Zhou

http://www.w3.org/2001/XMLSchema#string

Guo-Qiang Chen

http://www.w3.org/2001/XMLSchema#string

Jian-Rong He

http://www.w3.org/2001/XMLSchema#string

Jun Tang

http://www.w3.org/2001/XMLSchema#string

Meng-Na Zhan

http://www.w3.org/2001/XMLSchema#string

Ming He

http://www.w3.org/2001/XMLSchema#string

Qian Zhao

http://www.w3.org/2001/XMLSchema#string

Qian-Qian Yin

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors

Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1

Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer

Most mammalian mRNAs are conserved targets of microRNAs

MicroRNA signatures in human cancers

P304

1288-1299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.6339

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284713996

http://www.w3.org/2001/XMLSchema#string

P698

26595523

http://www.w3.org/2001/XMLSchema#string

P932

4811460

http://www.w3.org/2001/XMLSchema#string